Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Ablynx N v patents

Recent patent applications related to Ablynx N v. Ablynx N v is listed as an Agent/Assignee. Note: Ablynx N v may have other listings under different names/spellings. We're not affiliated with Ablynx N v, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Ablynx N v-related inventors




Date Ablynx N v patents (updated weekly) - BOOKMARK this page
07/06/17Improved tnf binders
06/15/17Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
05/18/17Kv1.3 binding immunoglobulins
05/04/17Improved immunoglobulin variable domains
04/20/17Stabilized single domain antibodies
04/06/17Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
04/06/17Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
03/23/17Method for the production of domain antibodies
03/23/17Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
12/22/16Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
11/17/16Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
10/06/16Amino acid sequences that modulate the interaction between cells of the immune system
09/29/16Stable formulations of polypeptides and uses thereof
09/29/16Amino acid sequences that modulate the interaction between cells of the immune system
09/15/16Formulations of single domain antigen binding molecules
09/15/16Method for generation of immunoglobulin sequences
09/01/16Bispecific nanobodies
06/02/16Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
03/31/16Stable formulations of immunoglobulin single variable domains and uses thereof
12/10/15Nanobodies against tumor necrosis factor-alpha
12/03/15Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
10/29/15Biological materials related to c-met
10/22/15Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor
10/22/15Amino acid sequences directed against cellular receptors for viruses and bacteria
09/24/15Amino acid sequences that modulate the interaction between cells of the immune system
08/20/15Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors
08/06/15Single variable domain antibodies against ox40l, constructs and therapeutic use
05/14/15P2x7 receptor antagonists and agonists
04/30/15Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections
04/23/15Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
04/23/15Biological materials related to cxcr7
04/02/15Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
03/05/15Stabilized single domain antibodies
02/19/15Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
02/19/15Prolonged inhibition of interleukin-6 mediated signaling
02/12/15Pseudomonas aeruginosa pcrv binding single variable domain antibodies
02/05/15Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
01/22/15Method for the production of variable domains
01/08/15Sequences directed against hepatocyte growth factor (hfg) and polypeptides comprising the same for the treatment of cancers and/or tumors
11/27/14Interleukin-6 receptor binding polypeptides
11/27/14Interleukin-6 receptor binding polypeptides
11/20/14Biological materials related to c-met
11/20/14Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
11/13/14Nanobodies against tumor necrosis factor-alpha
11/06/14Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
10/02/14Biological materials related to c-met
08/14/14Serum albumin binding proteins
08/07/14Interleukin-6 receptor binding polypeptides
07/31/14Prolonged inhibition of interleukin-6 mediated signaling
07/24/14Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
07/24/14Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
07/17/14Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
06/26/14Stable formulations of polypeptides and uses thereof
06/26/14Biological materials related to cxcr7
06/19/14Inhibition of bone resorption with rankl binding peptides
05/22/14Method for the production of immunoglobulin single variable domains
03/06/14Method for producing solid formulations comprising immunoglobulin single variable domains
02/13/14Von willebrand factor specific binders and methods of use therefor
10/03/13Method for the production of immunoglobulin single variable domains
05/30/13Single domain vhh antibodies against von willebrand factor
05/30/13Pulmonary administration of immunoglobulin single variable domains and constructs thereof
05/23/13Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
05/02/13Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine il-23
01/24/13Methods and compositions for the preparation of aerosols
01/17/13Single variable domain antibodies against ox40l, constructs and therapeutic use
Patent Packs
01/10/13Delivery of immunoglobulin variable domains and constructs thereof
12/20/12Von willebrand factor specific binding agents and uses thereof
11/29/12Amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
10/18/12Biparatopic protein constructs directed against il-23
10/04/12Stabilized single domain antibodies
10/04/12Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
09/27/12Stable formulations of polypeptides and uses thereof
09/27/12Biological materials related to c-met
09/06/12Stable formulations of immunoglobulin single variable domains and uses thereof
08/09/12Stable formulations of polypeptides and uses thereof
08/09/12Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
07/05/12Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
06/21/12Method for the production of domain antibodies
06/14/12Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof
06/07/12Method for the production of variable domains
Patent Packs
05/24/12Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections
04/19/12Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
03/29/12Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
03/29/12Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
02/16/12Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
12/29/11Amino acid sequences targeting human cd4, cxcr4, ccr5, tlr4, alphav integrin, beta3-integrin, beta1-integrin, human alpha2-integrin, cd81, sr-bi, claudin-1, claudin-6 and claudin-9, respectively, and neutralizing viral entry
12/22/11Pulmonary administration of immunoglobulin single variable domains and constructs thereof
12/01/11Amino acid sequences directed against multitarget scavenger receptors and polypeptides
12/01/11Amino acid sequences directed against integrins and uses thereof
11/17/11Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
10/27/11Amino acid sequences that modulate the interaction between cells of the immune system
10/27/11Biological materials related to cxcr7
10/06/11Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
08/25/11Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same
08/04/11Immunoglobulin constructs
07/28/11Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
07/28/11Method of administering therapeutic polypeptides, and polypeptides therefor
07/28/11Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
07/28/11Single domain antibodies directed against epidermal growth factor receptor and uses therefor
07/21/11Stabilized single domain antibodies
06/30/11Von willebrand factor specific binders and methods of use therefor
06/02/11Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
05/26/11Single domain antibodies directed against epidermal growth factor receptor and uses therefor
05/19/11Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
04/21/11Novel antigen binding dimer-complexes, methods of making and uses thereof
03/10/11Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors
03/10/11Amino acid sequences directed against il-6 and polypetides comprising the same for the treatment of diseases and disorders associated with il-6 mediated signalling
03/03/11Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
02/03/11Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
01/27/11Needle-free delivery device for therapeutic proteins based on single antigen-binding domains such as nanobodies®
Social Network Patent Pack
01/06/11Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
12/30/10Single domain vhh antibodies against von willebrand factor
09/09/10Medical delivery device for therapeutic proteins based on single domain antibodies
08/26/10Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6 -mediated signalling
08/26/10Amino acid sequences that bind to a desired molecule in a conditional manner
07/08/10Method for generation of immunoglobulin sequences
06/17/10Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
06/03/10Anti-fc-receptor single domain antibodies (nanobodies-tm) and therapeutic use
05/27/10Intranasal delivery of polypeptides and proteins
05/27/10Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof
Patent Packs
05/13/10Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
04/29/10Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
04/15/10Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders
03/11/10Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
02/18/10Polypeptide constructs for sublingual administration
02/04/10Amino acid sequences that modulate the interaction between cells of the immune system
01/28/10Polypeptide constructs for intracellular delivery
01/28/10Nanobodies for the treatment of aggregation-mediated disorders
01/07/10Polypeptide constructs for rectal and/or vaginal administration
01/07/10Polypeptide constructs for topical administration
01/07/10Single domain antibodies directed against epidermal growth factor receptor and uses therefor
12/31/09Polypeptide constructs for nasal administration
12/03/09Amino acid sequences directed against il-6 and polypetides comprising the same for the treatment of diseases and disorders associated with il-6 mediated signalling
11/19/09Dp-78-like nanobodies
11/12/09Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
10/08/09Nanobodies and polypeptides against egfr and igf-ir
09/24/09Stabilized single domain antibodies
03/19/09Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ablynx N v in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ablynx N v with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';